Sangel Biomedical Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 2
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Drug Discovery
Summary

The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2018.

Among the most popular fund investment industries, there are Medical Device, Medical. The fund has exact preference in some founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Quantapore, Sirnaomics Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Sangel Biomedical Venture Capital, startups are often financed by Value Measured Investment Limited, Maryland Department of Business and Economic Development, China BioPharma Capital I. The meaningful sponsors for the fund in investment in the same round are Tsingyuan Ventures, Qianhai Shenghui Investment, Northern Light Venture Capital. In the next rounds fund is usually obtained by Rolling Boulder Investment, Rich Yield Capital, Legend Sky Investment.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sangel Biomedical Venture Capital:
Typical Co-investors
Sangel Biomedical Venture Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sangel Biomedical Venture Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aditya Birla Financial Services -
CanCode -
Cue Ball, LLC Boulder, Colorado, United States
Governor of Virginia Richmond, United States, Virginia
Guodian Dianli China, Dalian, Zhejiang
HackerOne California, San Francisco, United States
HITO-Communications Japan, Toshima
Jiaxing Hongliu Investment -
Kuake Capital Chaoyang, China, Liaoning
Louisiana Board of Regents Baton Rouge, Louisiana, United States
LVP England, London, United Kingdom
MIT Solve Cambridge, Massachusetts, United States
Orgain California, Irvine, United States
Orient Hontai Capital Beijing, Beijing, China
Point72 Connecticut, Stamford, United States
QianHai Equity Investment China, Guangdong, Shenzhen
Stockton & Partners Pennsylvania, Philadelphia, United States
Swedish Energy Agency Eskilstuna, Sodermanlands Lan, Sweden
Vetrargil Gullbringusysla, Iceland, Reykjavík

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Quantapore

Biotechnology
Health Care
Medical
$17M19 Jul 2018 California, United States

Sirnaomics

Biopharma
Biotechnology
Drug Discovery
Medical Device
Pharmaceutical
$25M06 Jun 2018 Maryland, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sangel Biomedical Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: